Gut bacteria during infection may flag IBS risk

NCT ID NCT03223077

Recruiting now Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study looks at how a Campylobacter gut infection changes the bacteria and lining of the bowel, and whether these changes can help identify who might later develop irritable bowel syndrome (IBS). Researchers will follow people with a confirmed Campylobacter infection who do not have a history of IBS or other bowel diseases. The goal is to see if certain gut changes during the acute infection are linked to the development of IBS afterward.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help identify people at higher risk for developing IBS after a gut infection, potentially leading to early interventions or preventive strategies.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The findings may not apply to all populations, and the link between gut bacteria and IBS risk may be complex and influenced by many factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAMPYLOBACTER ENTERITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

campylobacteriosis irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRRITABLE BOWEL SYNDROME

Contacts and locations

Locations

Mayo Clinic
RECRUITING

Rochester, Minnesota, 55902, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.